Immunocapture-based fluorometric assay for the measurement of neprilysin-specific enzyme activity in brain tissue homogenates and cerebrospinal fluid - PubMed (original) (raw)
Immunocapture-based fluorometric assay for the measurement of neprilysin-specific enzyme activity in brain tissue homogenates and cerebrospinal fluid
James Scott Miners et al. J Neurosci Methods. 2008.
Abstract
Neprilysin, a zinc-metalloendopeptidase, has important roles in the physiology and pathology of many diseases such as hypertension, cancer and Alzheimer's disease. We have developed an immunocapture assay to measure the specific enzyme activity of neprilysin in brain tissue homogenates and cerebrospinal fluid (CSF). The assay uses a neprilysin-specific antibody, previously used in a commercially available ELISA kit, to isolate and immobilise NEP from brain homogenates and CSF, prior to the addition of a fluorogenic peptide substrate (Mca-RPPGFSAFK(Dnp)). This fluorogenic substrate is ordinarily cleaved by multiple enzymes. We have shown that without the immunocapture phase, even under reaction conditions reported to be specific for neprilysin - i.e. in the presence of thiorphan, at pH above 7 - the fluorogenic peptide substrate does not allow neprilysin activity in brain homogenates and CSF to be discriminated from that of other closely related enzymes. The specificity of the immunocapture enzyme activity assay was confirmed by >80% inhibition of substrate cleavage in brain homogenates and CSF in the presence of thiorphan. The assay allows high-throughput analysis and, critically, also ensures a high level of enzyme specificity even when assaying crude tissue homogenates or CSF.
Similar articles
- Immunocapture-based fluorometric assay for the measurement of insulin-degrading enzyme activity in brain tissue homogenates.
Miners JS, Kehoe PG, Love S. Miners JS, et al. J Neurosci Methods. 2008 Mar 30;169(1):177-81. doi: 10.1016/j.jneumeth.2007.12.003. Epub 2007 Dec 17. J Neurosci Methods. 2008. PMID: 18221786 - A highly selective assay for neutral endopeptidase based on the cleavage of a fluorogenic substrate related to Leu-enkephalin.
Carvalho KM, Boileau G, Camargo AC, Juliano L. Carvalho KM, et al. Anal Biochem. 1996 Jun 1;237(2):167-73. doi: 10.1006/abio.1996.0224. Anal Biochem. 1996. PMID: 8660561 - Thiorphan-induced neprilysin inhibition raises amyloid beta levels in rabbit cortex and cerebrospinal fluid.
Newell AJ, Sue LI, Scott S, Rauschkolb PK, Walker DG, Potter PE, Beach TG. Newell AJ, et al. Neurosci Lett. 2003 Oct 30;350(3):178-80. doi: 10.1016/s0304-3940(03)00902-9. Neurosci Lett. 2003. PMID: 14550923 - Beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) as a biological candidate marker of Alzheimer's disease.
Hampel H, Shen Y. Hampel H, et al. Scand J Clin Lab Invest. 2009;69(1):8-12. doi: 10.1080/00365510701864610. Scand J Clin Lab Invest. 2009. PMID: 18609117 Review. - [Evolution of IGRA researches].
Ariga H, Harada N. Ariga H, et al. Kekkaku. 2008 Sep;83(9):641-52. Kekkaku. 2008. PMID: 18979999 Review. Japanese.
Cited by
- Mechanisms of Amyloid-β Peptide Clearance: Potential Therapeutic Targets for Alzheimer's Disease.
Yoon SS, Jo SA. Yoon SS, et al. Biomol Ther (Seoul). 2012 May;20(3):245-55. doi: 10.4062/biomolther.2012.20.3.245. Biomol Ther (Seoul). 2012. PMID: 24130920 Free PMC article. Review. - Genetic variation in MME in relation to neprilysin protein and enzyme activity, Aβ levels, and Alzheimer's disease risk.
Miners S, van Helmond Z, Barker R, Passmore PA, Johnston JA, Todd S, McGuinness BM, Panza F, Seripa D, Solfrizzi V, Love S, Prince JA, Kehoe PG. Miners S, et al. Int J Mol Epidemiol Genet. 2012;3(1):30-8. Epub 2012 Feb 5. Int J Mol Epidemiol Genet. 2012. PMID: 22493749 Free PMC article. - Beneficial Effects of Combined AT1 Receptor/Neprilysin Inhibition (ARNI) Versus AT1 Receptor Blockade Alone in the Diabetic Eye.
Prasad T, Roksnoer LC, Zhu P, Verma A, Li Y, Batenburg WW, de Vries R, Danser AH, Li Q. Prasad T, et al. Invest Ophthalmol Vis Sci. 2016 Dec 1;57(15):6722-6730. doi: 10.1167/iovs.16-20289. Invest Ophthalmol Vis Sci. 2016. PMID: 27951594 Free PMC article. - Neprilysin protects against cerebral amyloid angiopathy and Aβ-induced degeneration of cerebrovascular smooth muscle cells.
Miners JS, Kehoe P, Love S. Miners JS, et al. Brain Pathol. 2011 Sep;21(5):594-605. doi: 10.1111/j.1750-3639.2011.00486.x. Epub 2011 Apr 3. Brain Pathol. 2011. PMID: 21382117 Free PMC article. - Co-Administration of TiO2 Nanowired Mesenchymal Stem Cells with Cerebrolysin Potentiates Neprilysin Level and Reduces Brain Pathology in Alzheimer's Disease.
Sharma HS, Muresanu DF, Lafuente JV, Patnaik R, Tian ZR, Ozkizilcik A, Castellani RJ, Mössler H, Sharma A. Sharma HS, et al. Mol Neurobiol. 2018 Jan;55(1):300-311. doi: 10.1007/s12035-017-0742-9. Mol Neurobiol. 2018. PMID: 28844104 Retracted.